Assembly Biosciences, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Assembly Biosciences, Inc. (ASMB) reported Increase (Decrease) in Prepaid Expense and Other Assets of $1.33 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-13
- Assembly Biosciences, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $1.23M.
- Assembly Biosciences, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $92.00K, a 91.44% decline year-over-year.
- Assembly Biosciences, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $2.13M, a 1188.48% increase year-over-year.
- Assembly Biosciences, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $856.00K.
- Assembly Biosciences, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $2.04M.
- Assembly Biosciences, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$73.00K.
- Assembly Biosciences, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$916.00K.
- Assembly Biosciences, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$1.33M.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.33M 10-Q · filed 2026-08-13 | $3.45M derived: sum of 3 quarters · filed 2026-08-13 | $4.31M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $92.00K 10-Q · filed 2026-05-07 | $2.22M derived: sum of 2 quarters · filed 2026-05-07 | $3.07M derived: sum of 3 quarters · filed 2026-05-07 | $1.06M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $2.98M derived: sum of 2 quarters · filed 2026-03-19 | $970.00K derived: sum of 3 quarters · filed 2026-08-13 | $2.04M 10-K · filed 2026-03-19 | ||||
| 2025-09-30 | $856.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$1.16M derived: sum of 2 quarters · filed 2026-08-13 | -$81.00K 10-Q · filed 2025-11-10 | $84.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | -$2.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$937.00K 10-Q · filed 2026-08-13 | -$772.00K derived: sum of 3 quarters · filed 2026-08-13 | -$1.23M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $1.07M 10-Q · filed 2026-05-07 | $1.24M derived: sum of 2 quarters · filed 2026-05-07 | $787.00K derived: sum of 3 quarters · filed 2026-05-07 | $350.00K derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $165.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$288.00K derived: sum of 2 quarters · filed 2026-03-19 | -$725.00K derived: sum of 3 quarters · filed 2026-03-19 | -$73.00K 10-K · filed 2026-03-19 | ||||
| 2024-09-30 | -$453.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$890.00K derived: sum of 2 quarters · filed 2025-11-10 | -$238.00K 10-Q · filed 2025-11-10 | -$203.00K derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | -$437.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $215.00K 10-Q · filed 2025-08-06 | $250.00K derived: sum of 3 quarters · filed 2025-08-06 | -$196.00K derived: sum of 4 quarters · filed 2025-08-06 | ||||
| 2024-03-31 | $652.00K 10-Q · filed 2025-05-08 | $687.00K derived: sum of 2 quarters · filed 2025-05-08 | $241.00K derived: sum of 3 quarters · filed 2025-05-08 | -$1.86M derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$411.00K derived: sum of 2 quarters · filed 2025-03-20 | -$2.51M derived: sum of 3 quarters · filed 2025-03-20 | -$916.00K 10-K · filed 2025-03-20 | ||||
| 2023-09-30 | -$446.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$2.55M derived: sum of 2 quarters · filed 2024-11-07 | -$951.00K 10-Q · filed 2024-11-07 | -$219.00K derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | -$2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$505.00K 10-Q · filed 2024-08-08 | $227.00K derived: sum of 3 quarters · filed 2024-08-08 | -$1.67M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $1.60M 10-Q · filed 2024-05-08 | $2.33M derived: sum of 2 quarters · filed 2024-05-08 | $429.00K derived: sum of 3 quarters · filed 2024-05-08 | $258.00K derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | $732.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$1.17M derived: sum of 2 quarters · filed 2024-03-28 | -$1.34M derived: sum of 3 quarters · filed 2024-03-28 | -$1.33M 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | -$1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$2.07M derived: sum of 2 quarters · filed 2023-11-08 | -$2.06M 10-Q · filed 2023-11-08 | -$2.87M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | -$171.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$159.00K 10-Q · filed 2023-08-09 | -$966.00K derived: sum of 3 quarters · filed 2023-08-09 | -$602.00K derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | $12.00K 10-Q · filed 2023-05-04 | -$795.00K derived: sum of 2 quarters · filed 2023-05-04 | -$431.00K derived: sum of 3 quarters · filed 2023-05-04 | -$794.00K derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | -$807.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$443.00K derived: sum of 2 quarters · filed 2023-03-22 | -$806.00K derived: sum of 3 quarters · filed 2023-03-22 | -$1.11M 10-K · filed 2023-03-22 | ||||
| 2021-09-30 | $364.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $1.00K derived: sum of 2 quarters · filed 2022-11-08 | -$302.00K 10-Q · filed 2022-11-08 | $1.69M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | -$363.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$666.00K 10-Q · filed 2022-08-09 | $1.33M derived: sum of 3 quarters · filed 2022-08-09 | $1.13M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | -$303.00K 10-Q · filed 2022-05-12 | $1.69M derived: sum of 2 quarters · filed 2022-05-12 | $1.49M derived: sum of 3 quarters · filed 2022-05-12 | $1.98M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $1.79M derived: sum of 2 quarters · filed 2022-03-11 | $2.28M derived: sum of 3 quarters · filed 2022-03-11 | $1.49M 10-K · filed 2022-03-11 | ||||
| 2020-09-30 | -$203.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $288.00K derived: sum of 2 quarters · filed 2021-11-04 | -$507.00K 10-Q · filed 2021-11-04 | -$585.00K derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $491.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$304.00K 10-Q · filed 2021-08-05 | -$382.00K derived: sum of 3 quarters · filed 2021-08-05 | -$1.69M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | -$795.00K 10-Q · filed 2021-05-06 | -$873.00K derived: sum of 2 quarters · filed 2021-05-06 | -$2.18M derived: sum of 3 quarters · filed 2021-05-06 | $332.00K derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | -$78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$1.38M derived: sum of 2 quarters · filed 2021-02-25 | $1.13M derived: sum of 3 quarters · filed 2021-02-25 | $3.69M 10-K · filed 2021-02-25 | ||||
| 2019-09-30 | -$1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.21M derived: sum of 2 quarters · filed 2020-11-05 | $3.76M 10-Q · filed 2020-11-05 | $2.41M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | $2.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $5.07M 10-Q · filed 2020-08-05 | $3.72M derived: sum of 3 quarters · filed 2021-02-25 | $4.33M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $2.56M 10-Q · filed 2020-05-08 | $1.21M derived: sum of 2 quarters · filed 2021-02-25 | $1.82M derived: sum of 3 quarters · filed 2021-02-25 | $2.75M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | -$1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$740.00K derived: sum of 2 quarters · filed 2021-02-25 | $188.00K derived: sum of 3 quarters · filed 2021-02-25 | $1.09M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $611.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $1.54M derived: sum of 2 quarters · filed 2019-11-07 | $2.44M 10-Q · filed 2019-11-07 | $2.45M 10-Q · filed 2018-11-08 | $2.39M derived: sum of 4 quarters · filed 2020-03-04 | |||
| 2018-06-30 | $928.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $1.83M 10-Q · filed 2019-08-05 | $1.83M 10-Q · filed 2018-08-08 | $1.78M derived: sum of 3 quarters · filed 2020-03-04 | $1.75M derived: sum of 4 quarters · filed 2020-03-04 | |||
| 2018-03-31 | $906.00K 10-Q · filed 2019-05-09 | $905.67K 10-Q · filed 2018-05-07 | $851.84K derived: sum of 2 quarters · filed 2020-03-04 | $824.82K derived: sum of 3 quarters · filed 2020-03-04 | $504.50K derived: sum of 4 quarters · filed 2020-03-04 | |||
| 2017-12-31 | -$54.16K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | -$81.18K derived: sum of 2 quarters · filed 2020-03-04 | -$401.50K derived: sum of 3 quarters · filed 2020-03-04 | $286.00K 10-K · filed 2020-03-04 | $286.22K 10-K · filed 2018-03-08 | |||
| 2017-09-30 | -$27.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$347.34K derived: sum of 2 quarters · filed 2018-11-08 | $340.16K 10-Q · filed 2018-11-08 | $342.09K derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-06-30 | -$320.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $367.18K 10-Q · filed 2018-08-08 | $369.12K derived: sum of 3 quarters · filed 2019-02-28 | $421.82K derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-03-31 | $687.50K 10-Q · filed 2018-05-07 | $689.43K derived: sum of 2 quarters · filed 2019-02-28 | $742.14K derived: sum of 3 quarters · filed 2019-02-28 | $533.10K derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2016-12-31 | $1.94K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $54.64K derived: sum of 2 quarters · filed 2019-02-28 | -$154.39K derived: sum of 3 quarters · filed 2019-02-28 | -$93.00K 10-K · filed 2019-02-28 | -$93.11K 10-K · filed 2017-03-02 | |||
| 2016-09-30 | $52.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | -$156.33K derived: sum of 2 quarters · filed 2017-11-01 | -$94.94K 10-Q · filed 2017-11-01 | |||||
| 2016-06-30 | -$209.04K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$147.64K 10-Q · filed 2017-08-09 | ||||||
| 2016-03-31 | $61.39K 10-Q · filed 2017-05-08 | |||||||
| 2015-12-31 | $555.85K 10-K · filed 2018-03-08 | |||||||
| 2014-12-31 | $54.47K 10-K · filed 2017-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |